ARPA-H's TIGAR program funds bold research on non-cryogenic, temperature-flexible methods for preserving complex human tissues and organs to advance transplantation and regenerative medicine.
Funder: Advanced Research Projects Agency for Health
Due Dates: June 8, 2026 (Solution Video) | August 5, 2026 (Full Proposal)
Funding Amounts: Up to $2 million per award; project duration up to 18 months (two 9-month phases).
Summary: Funding for high-risk, innovative research to advance temperature-flexible, non-cryogenic tissue and organ preservation technologies.
Key Information: Submission of a Solution Video is required to be eligible for a full proposal.
The Technology InteGrator and AcceleratoR (TIGAR) Exploratory Topic is an ARPA-H initiative focused on accelerating research in advanced tissue and organ preservation. The program seeks bold, early-stage solutions to stabilize complex human tissues at various temperatures, extend their storage duration, and restore functionality post-storage. TIGAR explicitly prioritizes non-cryogenic, temperature-flexible approaches to overcome the limitations of current biopreservation methods, with the aim of expanding access to transplantation and regenerative medicine. Funded projects are expected to deliver proof-of-concept results rapidly, laying the groundwork for future breakthroughs in the field.